Cancer stem cells in hepatocellular carcinoma—from origin to clinical implications

TKW Lee, XY Guan, S Ma - Nature reviews Gastroenterology & …, 2022 - nature.com
Hepatocellular carcinoma (HCC) is an aggressive disease with a poor clinical outcome. The
cancer stem cell (CSC) model states that tumour growth is powered by a subset of tumour …

Global epidemiology and genetics of hepatocellular carcinoma

MR Toh, EYT Wong, SH Wong, AWT Ng, LH Loo… - Gastroenterology, 2023 - Elsevier
Hepatocellular carcinoma (HCC) is one of the leading cancers worldwide. Classically, HCC
develops in genetically susceptible individuals who are exposed to risk factors, especially in …

Diagnosis and management of cirrhosis and its complications: a review

EB Tapper, ND Parikh - Jama, 2023 - jamanetwork.com
Importance Cirrhosis affects approximately 2.2 million adults in the US. From 2010 to 2021,
the annual age-adjusted mortality of cirrhosis increased from 14.9 per 100 000 to 21.9 per …

Oxidative stress in liver pathophysiology and disease

A Allameh, R Niayesh-Mehr, A Aliarab, G Sebastiani… - Antioxidants, 2023 - mdpi.com
The liver is an organ that is particularly exposed to reactive oxygen species (ROS), which
not only arise during metabolic functions but also during the biotransformation of …

[HTML][HTML] Hepatocellular carcinoma in viral and autoimmune liver diseases: role of CD4+ CD25+ Foxp3+ regulatory T cells in the immune microenvironment

A Granito, L Muratori, C Lalanne… - World journal of …, 2021 - ncbi.nlm.nih.gov
More than 90% of cases of hepatocellular carcinoma (HCC) occurs in patients with cirrhosis,
of which hepatitis B virus and hepatitis C virus are the leading causes, while the tumor less …

Diagnosis and management of autoimmune hepatitis

L Muratori, AW Lohse, M Lenzi - bmj, 2023 - bmj.com
Autoimmune hepatitis is an inflammatory disease of the liver of unknown cause that may
progress to liver cirrhosis and end stage liver failure if diagnosis is overlooked and treatment …

Lipid based nanoparticles as a novel treatment modality for hepatocellular carcinoma: a comprehensive review on targeting and recent advances

K Mahmoud, S Swidan, M El-Nabarawi… - Journal of …, 2022 - Springer
Liver cancer is considered one of the deadliest diseases with one of the highest disease
burdens worldwide. Among the different types of liver cancer, hepatocellular carcinoma is …

The landscape of gene mutations in cirrhosis and hepatocellular carcinoma

M Müller, TG Bird, JC Nault - Journal of hepatology, 2020 - Elsevier
Chronic liver disease and primary liver cancer are a massive global problem, with a future
increase in incidences predicted. The most prevalent form of primary liver cancer …

[HTML][HTML] Real-world data on the diagnosis, treatment, and management of hepatocellular carcinoma in the Asia-Pacific: the INSIGHT study

YK Sim, MC Chong, M Gandhi, YM Pokharkar, Y Zhu… - Liver Cancer, 2024 - karger.com
Introduction: Hepatocellular carcinoma (HCC) is the sixth most commonly diagnosed cancer
and the third leading cause of cancer death worldwide. While there has been rapid evolution …

EASL clinical practice guidelines on haemochromatosis

H Zoller, B Schaefer, A Vanclooster, B Griffiths… - Journal of …, 2022 - Elsevier
Haemochromatosis is characterised by elevated transferrin saturation (TSAT) and
progressive iron loading that mainly affects the liver. Early diagnosis and treatment by …